Effect of short term intensive multitherapy on carotid intima-media thickness in patients with newly diagnosed type 2 diabetes mellitus

Chinese Medical Journal

Volumn 121, Issue 8, 2008, Pages 687-690

  Guo, Li Xin ^a   Pan, Qi ^a   Wang, Xiao Xia ^a   Li, Hui ^a   Zhang, Li Na ^a   Chi, Jia Min ^a   Wang, Yao ^a  

^a BEIJING HOSPITAL   (China)

Author keywords

Carotid intima media thickness; Intensive multitherapy; Type 2 diabetes

Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ALBUMIN; CAPTOPRIL; CHOLESTEROL; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NIFEDIPINE; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BEDTIME DOSAGE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIET THERAPY; DISEASE COURSE; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 51149088732     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200804020-00005     Document Type: Article

References (22)

1. UK Prospective Diabetes Study Group. VIII: Study design, progress and performance. Diabetologia 1991; 34: 877-890.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-853.
3. Krentz AJ, Bailey CJ. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005; 65: 385-411.
4. Gaede P, Vedel P, Larsen N, Jensen GV. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
5. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitter M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2006; 37: 87-92.
6. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115: 459-467.
7. Kitamura A, Iso H, Imano H, Ohira T, Okada T, Sato S, et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004; 35: 2788-2794.
8. Touboul PJ, Elbaz A, Koller C, Lucas C, Adraï V, Chédru F, et, al. Common carotid artery intima-media thickness and brain infarction: the Etude du Profil Genetique de l'Infarctus Cerebral (GENIC) case-control study: the GENIC investigators. Circulation 2000; 102: 313-318.
9. Marre M. Reducing cardiovascular risk in diabetes. J Hypertens 2007; 25 Suppl 1: S19-22.
10. Toto RD. Heart disease in diabetic patients. Semin Nephrol 2005; 25: 372-378.
11. Pedersen O, Gaede P. Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study. Metabolism 2003; 52 (8 Suppl 1): 19-23.
12. Kawamoto R, Tomita H, Ohtsuka N, Inoue A, Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J Atheroscler Thromb 2007; 14: 78-85.
13. Temelkova-Kurktschiev TS, Koehler C, Leonhardt W, Schaper F, Henkel E, Siegert G, et al. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors. Diabetes Care 1999; 22: 333-338.
14. Hedblad B, Wikstrand J, Janzon L, Wedel H, Berglund G. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the beta-blocker cholesterol-lowering asymptomatic plaque study (BCAPS). Circulation 2001; 103: 1721-1726.
15. Lonn E, Yusuf S, Dzavik V, Boris C, Yi Q, Smith S, et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E. Circulation 2001; 103: 919-925.
16. Kodama M, Yamasaki Y, Sakamoto K, Yoshioka R, Matsuhisa M, Kajimoto Y, et al. Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb Res 2000; 97: 239-245.
17. Matsumoto K, Sera Y, Abe Y, Tominaga T, Yeki Y, Miyake S. Metformin attenuates progression of carotid arterial wall thickness in patients, with type 2 diabetes. Diabetes Res Clin Pract 2004; 64: 225-228.
18. Hosomi N, Mizushige K, Ohyama H, Takahashi T, Kitadai M, Hatanaka Y, et al. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke 2001; 32: 1539-1545.
19. Anderssen SA, Hjelstuen AK. Hjermann I. Bjerkan K. Holme I. Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives. Atherosclerosis 2005; 178: 387-397.
20. Taniwaki H, Kawagishi T, Emoto M, Shoji T, Kanda H, Maekawa K, et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes: vessel wall properties in type 2 diabetes. Diabetes Care 1999; 22: 1851-1857.
21. Yokoyama H, Aoki T, Imahori M, Kuramitsu M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave. Kidney Int 2004; 66: 448-454.
22. Watarai T. Yamasaki Y, Ikeda M. Kubota M. Kodama M. Tsujino T, et al. Insulin resistance contributes to carotid arterial wall thickness in patients with non-insulin-dependent diabetes mellitus. Endocrine J 1999; 46: 629-638.